Vimeo
LinkedIn
Instagram
Share |

firms

March 10, 2022

Companies developing robotic assistance for spine surgery, innovative treatment of cataracts, 3D cardiac modelling software, extracorporeal respiratory support systems and therapy for glaucoma surgery scar prophylaxis will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Forum on June 6 and 7.

Companies developing robotic assistance for spine surgery, innovative treatment of cataracts, 3D cardiac modelling software, extracorporeal respiratory support systems and therapy for glaucoma surgery scar prophylaxis will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Forum on June 6 and 7.

August 13, 2021

Cutting-edge venture stage innovations for chronic diseases with billion-dollar market potential will be presented to private investors at the Campden Wealth 31st MedTech Investing Europe Forum on 21-22 September, 2021.

Cutting-edge venture stage innovations for chronic diseases with billion-dollar market potential will be presented to private investors at the Campden Wealth 31st MedTech Investing Europe Forum on 21-22 September, 2021.

December 7, 2020

The acquisition of the $2.8 billion London-based family office Sandaire by Schroders did not come as a shock to some family office principals who say they anticipate further consolidation as financial institutions seek inroads into the $5.9 trillion family office space and family office principals near retirement age.

The acquisition of the $2.8 billion London-based family office Sandaire by Schroders did not come as a shock to some family office principals who say they anticipate further consolidation as financial institutions seek inroads into the $5.9 trillion family office space and family office principals near retirement age.

However, those principals acknowledged that the very wealthiest of families would always want their own financial services managed directly and discreetly inhouse, regardless of mounting business costs and uncertain investment returns.

Click here >>
Close